生命科学资讯
生物技术与制药领域的最新动态
Ionis scraps early candidate for Alzheimer’s in people with Down syndrome
Ionis scraps Alzheimer’s drug for people with Down syndrome
Supreme Court invalidates Trump tariffs based on emergency powers
Supreme Court tariff ruling lets stand Trump’s authority to target pharma
Roche gets FDA decision date on closely watched breast cancer drug
San Diego Upstart Drops $100 Genome Bombshell on Illumina - Hoodline
华尔街分析师对沃特世公司股票的目标价是多少？ - Barchart.com
What Are Wall Street Analysts' Target Price for Waters Corporation Stock? - Barchart.com
Biopharma money raised: Jan. 1-Feb. 19, 2026
Money raised by biopharma
TXG: UBS Raises Price Target for 10x Genomics to $20 | TXG Stock News - GuruFocus
溶酶体KICSTOR-GATOR1-SAMTOR营养感知超级复合物的结构
Structure of the lysosomal KICSTOR-GATOR1-SAMTOR nutrient-sensing supercomplex
生态困境中的共生固守
Symbiotic entrenchment through ecological Catch-22
Grail股价暴跌，因NHS-Galleri癌症血液检测关键试验未达主要终点。
Grail stock craters as key NHS-Galleri cancer blood test trial fails to hit primary endpoint
Mainz Biomed计划剥离ColoAlert业务，调整美国市场战略重心。
Mainz Biomed looks to shed ColoAlert, shifts focus in US
罗氏任命澳大利亚肿瘤学家领导早期研究——机遇与挑战并存
Chutes & Ladders—Roche taps Aussie oncologist to lead early research
Biohaven在FDA打击后规划回归之路，押注肥胖症市场。
Biohaven charts comeback path after FDA blow, placing bets on obesity